| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
IDRA-21 is a relatively new nootropic compound. It works as an ampakine stimulant drug and is currently being researched in regards to its effects in memory improvement, cognitive enhancement, stimulation, and reversing cognitive deficits.
IDRA-21 shows nootropic effects in animal studies, significantly improving learning and memory. It is around 10-30 times more potent than aniracetam in reversing cognitive deficits induced by orscopolamine,and produces sustained effects lasting for up to 48 hours after a single dose. The mechanism for this action is thought to be through promoting the induction of long-term potentiation between synapses in the brain.
IDRA-21 is classified as an ampakine. It is able to improve focus and attention as well as promote learning and memory. Ampakines are growing in popularity largely because they provide the cognitive benefits of stimulants without the undesirable side effects.
| Product name | IDRA 21 |
| CAS No. | 22503-72-6 |
| MF | C8H9ClN2O2S |
| MW | 232.69 |
| Melting point | 209 °C(Solv: acetic acid ) |
| Boiling point | 405.1±55.0 °C(Predicted) |
| Density | 1.394±0.06 g/cm3(Predicted) |
| Storage | Keep in dark place,Inert atmosphere,Room temperature |
){kind=link}